Numerous technologies that use and help nanovesicles to deliver drugs to disease sites have been developed over the past few years, as any regular reader of Medgadget can attest to. We’re now at a stage when figuring out how to manufacture so-called extracellular nanovesicles (ENV) in millions, properly targeted, and on demand is a major hurd (Read more...)